Keith C. Regnante
2018
In 2018, Keith C. Regnante earned a total compensation of $1.7M as Chief Financial Officer at Wave Life Sciences Ltd., a 122% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $142,800 |
|---|---|
| Option Awards | $668,510 |
| Salary | $350,000 |
| Stock Awards | $520,650 |
| Other | $9,060 |
| Total | $1,691,020 |
Regnante received $668.5K in option awards, accounting for 40% of the total pay in 2018.
Regnante also received $142.8K in non-equity incentive plan, $350K in salary, $520.7K in stock awards and $9.1K in other compensation.
Rankings
In 2018, Keith C. Regnante's compensation ranked 6,580th out of 14,244 executives tracked by ExecPay. In other words, Regnante earned more than 53.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,580 out of 14,244 | 54th |
Division Manufacturing | 2,520 out of 5,759 | 56th |
Major group Chemicals And Allied Products | 943 out of 2,122 | 56th |
Industry group Drugs | 791 out of 1,811 | 56th |
Industry Pharmaceutical Preparations | 618 out of 1,385 | 55th |
Source: SEC filing on June 26, 2019.
Regnante's colleagues
We found four more compensation records of executives who worked with Keith C. Regnante at Wave Life Sciences Ltd. in 2018.
2018
Paul Bolno
Wave Life Sciences Ltd.
Chief Executive Officer
2018
Michael Panzara
Wave Life Sciences Ltd.
Chief Medical Officer
2018
Chandra Vargeese
Wave Life Sciences Ltd.
Senior Vice President, Drug Discovery
2018
Christopher Francis
Wave Life Sciences Ltd.